Bradford J. Crutchfield
Net Worth

Last updated:

What is Bradford J. Crutchfield net worth?

The estimated net worth of Mr. Bradford J. Crutchfield is at least $43,606,697 as of 23 May 2022. He owns shares worth $1,306,710 as insider, has earned $40,549,987 from insider trading and has received compensation worth at least $1,750,000 in 10x Genomics, Inc..

What is the salary of Bradford J. Crutchfield?

Mr. Bradford J. Crutchfield salary is $350,000 per year as Chief Commercial Officer in 10x Genomics, Inc..

How old is Bradford J. Crutchfield?

Mr. Bradford J. Crutchfield is 62 years old, born in 1963.

What stocks does Bradford J. Crutchfield currently own?

As insider, Mr. Bradford J. Crutchfield owns shares in one company:

Company Title Shares Price per share Total value
10x Genomics, Inc. (TXG) Chief Commercial Officer 97,237 $13.44 $1,306,710

What does 10x Genomics, Inc. do?

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

TXG logo
TXG
10x Genomics, Inc.
$13.44

Bradford J. Crutchfield insider trading

10x Genomics, Inc.

Mr. Bradford J. Crutchfield has made 40 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he sold 286 units of TXG stock worth $13,947 on 23 May 2022.

The largest trade he's ever made was exercising 54,598 units of TXG stock on 21 Dec 2021. As of 23 May 2022 he still owns at least 97,237 units of TXG stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 286 $48.76 $13,947
Purchase
Class A Common Stock 158 $40.49 $6,397
Sale
Class A Common Stock 288 $78.6 $22,637
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Option
Class A Common Stock 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $95.13 $1,617,261
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Option
Class A Common Stock 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $121.53 $2,065,942
Option
Class A Common Stock 54,598 $3.12 $170,346
Option
Stock Option (right to buy) 54,598 $3.12 $170,346
Option
Class A Common Stock 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $139.99 $2,379,762
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Sale
Class A Common Stock 281 $148.38 $41,695
Sale
Class A Common Stock 17,000 $165.61 $2,815,336
Option
Class A Common Stock 17,000 $1.16 $19,720
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $157.51 $2,677,636
Option
Class A Common Stock 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $1.16 $19,720
Option
Class A Common Stock 17,000 $175.7 $2,986,832
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Sale
Class A Common Stock 14,700 $176.3 $2,591,610
Sale
Stock Option (right to buy) 2,300 $1.16 $2,668
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Sale
Class A Common Stock 270 $161.85 $43,699
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Option
Class A Common Stock 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $159.59 $2,712,962
Sale
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 17,000 $188.34 $3,201,797
Option
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Sale
Class A Common Stock 17,000 $191.49 $3,255,279
Sale
Class A Common Stock 17,000 $191.49 $3,255,279
Option
Class A Common Stock 17,000 $1.16 $19,720
Sale
Class A Common Stock 281 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 $186.25 $3,166,250
Sale
Class A Common Stock 17,000 $186.25 $3,166,250
Sale
Class A Common Stock 17,000 $78.79 $1,339,481
Option
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 17,000 $157.94 $2,684,980
Option
Stock Option (right to buy) 17,000 $1.16 $19,720
Option
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 33,645 N/A N/A
Option
Class A Common Stock 33,645 $3.12 $104,972
Option
Stock Option (right to buy) 33,645 $3.12 $104,972
Option
Class A Common Stock 33,645 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 $151.82 $2,580,940
Sale
Class A Common Stock 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 6,496 $137.76 $894,856
Sale
Class A Common Stock 6,496 N/A N/A
Option
Stock Option (right to buy) 6,496 N/A N/A
Option
Class A Common Stock 6,496 N/A N/A
Option
Stock Option (right to buy) 10,504 N/A N/A
Sale
Class A Common Stock 10,504 N/A N/A
Option
Class A Common Stock 10,504 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 3,224 N/A N/A
Option
Class A Common Stock 3,224 N/A N/A
Option
Stock Option (right to buy) 3,224 N/A N/A
Option
Stock Option (right to buy) 13,776 N/A N/A
Option
Class A Common Stock 13,776 N/A N/A
Sale
Class A Common Stock 13,776 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Option
Class A Common Stock 17,000 N/A N/A
Option
Stock Option (right to buy) 17,000 N/A N/A
Sale
Class A Common Stock 17,000 N/A N/A

10x Genomics key executives

10x Genomics, Inc. executives and other stock owners filed with the SEC: